Efficacy of an L- and N-type calcium channel blocker in hypertensive patients with neurovascular compression of the rostral ventrolateral medulla

Hypertension Research

Volumn 32, Issue 8, 2009, Pages 700-705

  Aota, Yasuko ^a   Morimoto, Satoshi ^a   Sakuma, Takao ^a   Morita, Tatsuyori ^a   Jo, Fusakazu ^a   Takahashi, Nobuyuki ^a   Maehara, Minoru ^a   Ikeda, Koshi ^a   Sawada, Satoshi ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CILNIDIPINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE MASS; HOME MONITORING; HUMAN; HYPERTENSION; MALE; MEDULLA OBLONGATA; MORNING DOSAGE; NERVE COMPRESSION; NEUROVASCULAR SYNDROME; NORADRENALIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; ROSTRAL VENTROLATERAL MEDULLA;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, N-TYPE; DIHYDROPYRIDINES; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MEDULLA OBLONGATA; MIDDLE AGED; NERVE COMPRESSION SYNDROMES; NOREPINEPHRINE; VENTRICULAR FUNCTION, LEFT;

EID: 68349121621     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.80     Document Type: Article

References (43)

1. Dampney RA, Goodchild AK, Robertson LG, Montgomery W. Role of ventrolateral medulla in vasomotor regulation: A correlative anatomical and physiological study. Brain Res Rev 1982; 249: 223-235.
2. Oshima N, Kumagai H, Onimaru H, Kawai A, Pilowsky PM, Iigaya K, Takimoto C, Hayashi K, Saruta T, Itoh H. Monosynaptic excitatory connection from the rostral ventrolateral medulla to sympathetic preganglionic neurons revealed by simultaneous recordings. Hypertens Res 2008; 31: 1445-1454.
3. Jannetta PJ, Gendell HM. Neurovascular compression associated with essential hypertension. Neurosurgery 1978; 2: 165.
4. Yamamoto I, Yamada S, Sato O. Microvascular decompression for hypertension-clinical and experimental study. Neurol Med Chir (Tokyo) 1991; 31: 1-6.
5. Kleineberg B, Becker H, Gaab MR, Naraghi R. Essential hypertension associated with neurovascular compression: Angiographic findings. Neurosurgery 1992; 30: 834-841.
6. Naraghi R, Gaab MR, Walter GF, Kleineberg B. Arterial hypertension and neurovascular compression at the ventrolateral medulla. A comparative microanatomical and pathological study. J Neurosurg 1992; 77 103-112.
7. Naraghi R, Geiger H, Crnac J, Huk W, Fahlbusch R, Engels G, Luft FC. Posterior fossa neurovascular anomalies in essential hypertension. Lancet 1994; 344: 1466-1470.
8. Kleineberg B, Becker H, Gaab MR. Neurovascular compression and essential hypertension. An angiographic study. Neuroradiology 1991; 33 2-8.
9. Akimura T, Furutani Y, Jimi Y, Saito K, Kashiwagi S, Kato S, Ito H. Essential hypertension and neurovascular compression at the ventrolateral medulla oblongata: MR evaluation. Am J Neuroradiol 1995; 16: 401-405.
10. Jannetta PJ, Segal R, Wolfson SK. Neurogenic hypertension: Etiology and surgical treatment. I. Observations in 53 patients. Ann Surg 1985; 201: 391-398.
11. Morimoto S, Sasaki S, Miki S, Kawa T, Itoh H, Nakata T, Takeda K, Nakagawa M, Kizu O, Furuya S, Naruse S, Maeda T. Neurovascular compression of the rostral ventrolateral medulla related to essential hypertension. Hypertension 1997; 30 (part 1): 77-82.
12. Morimoto S, Sasaki S, Miki S, Kawa T, Itoh H, Nakata T, Takeda K, Nakagawa M, Naruse S, Maeda T. Pulsatile compression of the rostral ventrolateral medulla in hypertension. Hypertension 1997; 29 (part 2): 514-518.
13. Jannetta PJ, Hamm IS, Jho HD, Saiki I. Essential hypertension caused by arterial compression of the left lateral medulla: A follow-up. Perspect Neurol Surg 1992; 3: 107-125.
14. Levy EL, Clyde B, McLaughlin MR, Jannetta PJ. Microvascular decompression of the left lateral medulla oblongata for severe refractory neurogenic hypertension. Neurosurgery 1998; 43: 1-6.
15. Morimoto S, Sasaki S, Itoh H, Nakata T, Takeda K, Nakagawa M, Furuya S, Naruse S, Fukuyama R, Fushiki S. Sympathetic activation and contribution of genetic factors in hypertension with neurovascular compression of the rostral ventrolateral medulla. J Hypertens 1999; 17: 1577-1582.
16. Makino Y, Kawano Y, Okuda N, Horio T, Iwashima Y, Yamada N, Takayama M, Takishita S. Autonomic function in hypertensive patients with neurovascular compression of the ventrolateral medulla oblongata. J Hypertens 1999; 17: 1257-1263.
17. Smith PA, Meaney JFM, Graham LN, Stoker JB, Mackintosh AF, Mary DASG, Ball SG. Relationship of neurovascular compression to central sympathetic discharge and essential hypertension. J Am Coll Cardiol 2004; 43: 1453-1458.
18. Sendeski MM, Consolim-Colombo FM, Leite CC, Ribira MC, Lessa P, Krieger EM. Increased sympathetic nerve activity correlates with neurovascular compression at the rostral ventrolateral medulla. Hypertension 2006; 47: 988-995.
19. Oike M, Inoue Y, Kitamura K, Kuriyama H. Dual action of FRC8653, a novel dihydropyridine derivative, on the Ba2+ current recorded from the rabbit basilar artery. Circ Res 1990; 67: 993-1006.
20. Uneyema H, Takahara A, Dohmoto H, Yoshimoto R, Inoue K, Akaike N. Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurons. Br J Pharmacol 1997; 122 32-42.
21. Takahara A, Fujita S, Moki K, Ono Y, Koganei H, Iwayama S, Yamamoto H. Neuronal Ca2+ channel blocking action of an antihypertensive drug, cilnidipine, in IMR=32 human neuroblastoma cells. Hypertens Res 2003; 26: 743-747.
22. Takahara A, Iwasaki H, Nakamura Y, Sugiyama A. Cardiac effects of L/ N-type Ca2+ channel blocker cilnidipine in anesthetized dogs. Eur J Pharmacol 2007; 565: 166-170.
23. Hirning LD, Fox AP, McCleskey EW, Olivera BM, Thayer SA, Miller RJ, Tsien RW. Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons. Science 1988; 239: 57-61.
24. Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, Miyakawa M, Fukiyama K. Japanese Society of Hypertension (JSH) Guidelines for Self-Monitoring of Blood Pressure at Home. Hypertens Res 2003; 26: 771-782.
25. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
26. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
27. Morimoto S, Sasaki S, Takeda K, Furuya S, Naruse S, Matsumoto K, Higuchi T, Saito M, Nakagawa M. Decreases in blood pressure and sympathetic nerve activity by microvascular decompression of the rostral ventrolateral medulla in essential hypertension. Stroke 1999; 30: 1707-1710.
28. Morimoto S, Aota Y, Sakuma T, Ichibangase A, Ikeda K, Sawada S, Iwasaka T. Efficacy of clonidine in a patient with refractory hypertension and chronic renal failure exhibiting neurovascular compression of the rostral ventrolateral medulla. Hypertens Res 2009; 32: 227-228.
29. World Health Organization International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
30. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Chapter 3. Principles of treatment. Hypertens Res 2009; 32: 24-28.
31. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214-1218.
32. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277: 739-745.
33. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
34. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003; 108: 560-565.
35. Burns J, Sivananthan MU, Ball SG, Mackintosh AF, Mary DASG, Greenwood JP. Relationship between central sympathetic drive and magnetic resonance imagingdetermined left ventricular mass in essential hypertension. Circulation 2007; 115: 1999-2005.
36. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Chapter 12. Secondary hypertension. Hypertens Res 2009; 32: 78-90.
37. Watterws MR, Burton BS, Turner GE, Cannard KR. MR screening for brain stem compression in hypertension. Am J Neuroradiol 1996; 17: 217-221.
38. Colon GP, Quint DJ, Dickinson LD, Brunberg JA, Jamerson KA, Hoff JT, Ross DA. Magnetic resonance evaluation of ventrolateral medullary compression in essential hypertension. J Neurosurg 1998; 88: 226-231.
39. Johnson DR, Coley SC, Brown J, Moseley IF. The role of MRI in screening for neurogenic hypertension. Neuroradiology 2000; 42: 99-103.
40. Hohenbleicher H, Schmitz SA, Koennecke HC, Offermann R, Offermann J, Zeytountchian H, Wolf KJ, Distler A, Sharma AM. Neurovascular contact of cranial nerve IX and X root-entry zone in hypertensive patients. Hypertension 2001; 37: 176-181.
41. Zikka J, Ceral J, Elias P, Tintera J, Kizo L, Solar M, Straka L. Vascular compression of rostral medulla oblongata: Prospective MR imaging study in hypertensive and normotensive subjects. Radiology 2004; 230: 65-69.
42. Goldmann A, Herzog T, Schaeffer J, Muehling M, Haubitz B, Haller H, Becker H, Radermacher J. Prevalence of neurovascular compression in patients with essential and secondary hypertension. Clin Nephrol 2007; 68: 357-366.
43. Morise T, Horita M, Kitagawa I, Shinzato R, Hoshiba Y, Masuya H, Suzuki M, Takekoshi N. The potent role of increased sympathetic tone in pathogenesis of essential hypertension with neurovascular compression. J Hum Hypertens 2000; 14: 807-811.